L & S Advisors’s Thermo Fisher Scientific TMO Stock Holding History

L & S Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,831	Closed	-$1.41M	–	364
2025 Q1	$1.41M	Buy	2,831 +289	+11%	+$157K	0.17%	147
2024 Q4	$1.32M	Sell	2,542 -5,132	-67%	-$2.82M	0.15%	158
2024 Q3	$4.75M	Buy	7,674 +4,684	+157%	+$2.77M	0.5%	61
2024 Q2	$1.65M	Buy	2,990 +103	+4%	+$59K	0.19%	138
2024 Q1	$1.68M	Buy	2,887 +431	+18%	+$242K	0.19%	138
2023 Q4	$1.3M	Buy	2,456 +182	+8%	+$88.1K	0.16%	146
2023 Q3	$1.15M	Buy	2,274 +54	+2%	+$28.8K	0.17%	142
2023 Q2	$1.16M	Sell	2,220 -358	-14%	-$193K	0.15%	142
2023 Q1	$1.49M	Sell	2,578 -338	-12%	-$191K	0.21%	115
2022 Q4	$1.61M	Sell	2,916 -155	-5%	-$82.1K	0.3%	93
2022 Q3	$1.56M	Sell	3,071 -655	-18%	-$367K	0.27%	89
2022 Q2	$2.02M	Sell	3,726 -456	-11%	-$251K	0.34%	71
2022 Q1	$2.47M	Sell	4,182 -10,980	-72%	-$6.31M	0.29%	100
2021 Q4	$10.1M	Buy	15,162 +1,241	+9%	+$775K	1.09%	21
2021 Q3	$7.95M	Buy	13,921 +5,431	+64%	+$2.98M	0.86%	26
2021 Q2	$4.28M	Sell	8,490 -9,647	-53%	-$4.55M	0.46%	66
2021 Q1	$8.28M	Buy	18,137 +3,258	+22%	+$1.56M	0.94%	15
2020 Q4	$6.93M	Buy	14,879 +961	+7%	+$451K	0.8%	23
2020 Q3	$6.14M	Buy	13,918 +5,303	+62%	+$2.19M	0.85%	26
2020 Q2	$3.12M	Sell	8,615 -313	-4%	-$105K	0.47%	66
2020 Q1	$2.53M	Sell	8,928 -631	-7%	-$199K	0.48%	46
2019 Q4	$3.11M	Sell	9,559 -505	-5%	-$153K	0.4%	62
2019 Q3	$2.93M	Sell	10,064 -6,397	-39%	-$1.83M	0.41%	70
2019 Q2	$4.83M	Sell	16,461 -532	-3%	-$147K	0.64%	41
2019 Q1	$4.65M	Buy	16,993 +6,491	+62%	+$1.62M	0.63%	47
2018 Q4	$2.35M	Sell	10,502 -20,486	-66%	-$4.81M	0.44%	51
2018 Q3	$7.56M	Buy	30,988 +10,384	+50%	+$2.39M	0.98%	28
2018 Q2	$4.27M	Buy	20,604 +13,019	+172%	+$2.76M	0.72%	38
2018 Q1	$1.57M	Buy	7,585 +2,455	+48%	+$515K	0.3%	83
2017 Q4	$974K	Buy	5,130 +615	+14%	+$118K	0.15%	127
2017 Q3	$854K	Hold	4,515	–	–	0.14%	127
2017 Q2	$788K	Buy	4,515 +845	+23%	+$142K	0.14%	138
2017 Q1	$564K	Buy	3,670 +2,050	+127%	+$313K	0.11%	144
2016 Q4	$229K	Sell	1,620 -9,777	-86%	-$1.44M	0.05%	152
2016 Q3	$1.81M	Sell	11,397 -887	-7%	-$137K	0.5%	59
2016 Q2	$1.81M	Buy	+12,284	New	+$1.81M	0.41%	59
2016 Q1	–	Sell	-31,102	Closed	-$4.41M	–	102
2015 Q4	$4.41M	Sell	31,102 -1,011	-3%	-$135K	1.11%	32
2015 Q3	$3.93M	Sell	32,113 -894	-3%	-$116K	1.14%	33
2015 Q2	$4.28M	Sell	33,007 -181	-0.5%	-$23.6K	1.09%	37
2015 Q1	$4.46M	Buy	33,188 +575	+2%	+$74.1K	1.17%	30
2014 Q4	$4.09M	Buy	32,613 +885	+3%	+$108K	1.28%	37
2014 Q3	$3.86M	Sell	31,728 -547	-2%	-$66.5K	1.89%	17
2014 Q2	$3.81M	Buy	32,275 +15,180	+89%	+$1.79M	1.52%	29
2014 Q1	$2.06M	Buy	+17,095	New	+$2.03M	1.1%	35

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

L & S Advisors's TMO Position: Q2 2025 in Review

L & S Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 2,831 shares — an estimated $1.41M sold.

L & S Advisors first reported a position in TMO in Q1 2014 and held it in 44 quarters. The position peaked at $10.1M in Q4 2021. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

L & S Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
L & S Advisors sold 2,831 Thermo Fisher Scientific shares in Q2 2025, an estimated $1.41M.
L & S Advisors first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 44 quarters.
L & S Advisors's Thermo Fisher Scientific position peaked at $10.1M in Q4 2021.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on L & S Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.